막유화(membrane emulsification, ME)는 SPG 막과 같이 균일한 크기의 세공을 갖는 막을 사용하여 좁은 입도분 포의 에멀젼을 제조하는 기술이다. 본 연구에서는 막유화법으로 형성시킨 다중 에멀젼을 사용하여 폴리카프로락톤(PCL) 마 이크로캡슐의 제조를 연구하였다. 먼저 초음파 유화기로 W1/O 단일 에멀젼을 제조한 후, premix 막유화를 적용하여 W1/O/W2 다중 에멀젼을 형성시킨 후 용매 증발을 통해 모델 약물인 BSA가 담지된 PCL 마이크로캡슐을 제조하였다. 연속상 에 대한 분산상의 비율(D/C ratio), PCL 농도, 유화제 농도, 모델 약물의 농도, 막간 압력차 등 막유화 변수가 제조된 마이크 로캡슐의 입경과 입도 분포에 미치는 영향을 실험하였다. Premix-ME를 적용하여 평균 입경 5~6 μm의 균일한 크기를 갖는 모델 약물 BSA의 함침량이 약 26%인 다중 코어형 PCL 마이크로캡슐을 제조할 수 있었다.

The membrane emulsification (ME) is a technology for producing emulsions with narrow size distribution by using the well-defined porous membranes such as the SPG membrane. In this work, the preparation of polycaprolactone (PCL) microcapsules by using the multiple emulsion membrane emulsification method was studied. After the making of W1/O single emulsions by sonication, then W1/O/W2 multiple emulsions were prepared by ME method. The effects of various parameters such as the ratio of disperse/continuous phase (D/C ratio), the contents of PCL, emulsifier and model drug and the transmembrane pressure on the size and distribution of PCL microcapsules were investigated. The uniform PCL microcapsules with about 5～6 μm of mean size were obtained. The model drug (BSA) release properties of the obtained PCL microcapsules also were tested.

Taraxaci Herba has long been used in herbal medicine for their choleretic, anti-heumatic and diuretic properties. In the present study, we investigated the effects of origin plants of Taraxaci Herba, Taraxacum coreanum Nakai, as an anti-inflammatory agent in lipopolysaccharide(LPS)-induced microglial activation in BV2 cells. NNMBS273, the EtOH extracts of roots T. coreanum was examined for anti-neuronal inflammatory activity as new drug development. The roots of T. coreanum, showed the potent anti-neuroinflammatory effects on LPS-induced inflammation in microglial BV2 cells. The anti-inflammatory effects of NNMBS273, the EtOH extracts of roots T. coreanum was demonstrated by the suppression of pro-inflammatory mediators, including pro-inflammatory enzymes (inducible nitric oxide synthase and cyclooxygenase-2) and cytokines (tumor necrosis factor-α and interleukin-1β). These results suggest that the roots T. coreanum may be a promising candidate for the treatment of neurodegenerative diseases related to neuroinflammation.

Glutamate-induced oxidative injury contributes to neuronal degeneration in many central nervous system (CNS) diseases, such as Parkinson’s disease, Alzheimer’s disease, epilepsy and ischemia. Inducible heme oxygenase (HO)-1 acts against oxidants that are thought to play a role in the pathogenesis of these diseases. The EtOH extracts of Viola mandshurica (NNMBS274), Viola patrinii (NNMBS275) and Viola papilionacea Pursh (NNMBS276), origin plants of Violae Herba, showed the potent neuroprotective effects on glutamate-induced neurotoxicity. Among them, NNMBS275, the extract of V. patrinii possessed the protective effects against glutamate toxicity by inducing the expression of heme oxygenase (HO)-1 in the mouse hippocampal HT22 cells. These results suggest that extracts of V. patrinii could be the effective candidates for the treatment of ROS-related neurological diseases. Furthermore, it is suggested that the protective effects of V. patrinii extract due to inducing the expression of HO-1 as an antioxidant/cytoprotective target